CBLL vs CL · rev $65.4M vs P/E 34, rev $20.38B
CeriBell, Inc (CBLL) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
CeriBell, Inc (CBLL) is a medical devices company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CBLL currently screens at market cap $768.1M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the CBLL and CL stock pages for the full models.
Not investment advice.